Development of an anti-HER2 single-chain variable antibody fragment construct for high-yield soluble expression in escherichia coli and one-step chromatographic purification
Set daily water targets, log intake throughout the day, and receive smart nudges when you're falling behind your goal
Viatris lawsuit is the one to watch 20312033: Most analysts' baseline forecast for final FDA approval and US market launch, assuming patents run their course 20332036: More conservative estimates accounting for remaining IP layers What could change this timeline: Further successful patent challenges by generic manufacturers Congressional or executive action to accelerate generic biologics access Expanded FDA streamlining of the biosimilar approval pathway For now, the cost relief available globally in 2026 will not reach US patients through the generic or biosimilar route
Longo, Geoffrey Dusheiko, Kosh Agarwal, Mala K
Higher GH and IGF-1 can support muscle protein synthesis and fat breakdown
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial